+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Choroidal Neovascularization - Pipeline Insight, 2025 - Product Thumbnail Image

Choroidal Neovascularization - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
House Dust Mite Allergy Market Report 2026 - Product Thumbnail Image

House Dust Mite Allergy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Hidradenitis Suppurativa Market Report 2026 - Product Thumbnail Image

Hidradenitis Suppurativa Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Cystic Fibrosis (CF) Therapeutics Market Report 2026 - Product Thumbnail Image

Cystic Fibrosis (CF) Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Anaphylaxis Treatment Market Report 2026 - Product Thumbnail Image

Anaphylaxis Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Nasal Polyps Treatment Market Report 2026 - Product Thumbnail Image

Nasal Polyps Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Angiosarcoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Angiosarcoma Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 390 Pages
  • Global
From
From
From
From
From
Urothelial Cancer Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

Urothelial Cancer Drugs - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 126 Pages
  • Global
From
MEK Inhibitors - Global Strategic Business Report - Product Thumbnail Image

MEK Inhibitors - Global Strategic Business Report

  • Report
  • November 2026
  • 132 Pages
  • Global
From
Stomach Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Stomach Cancer Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 371 Pages
  • Global
From
Oral Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Oral Cancer Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 279 Pages
  • Global
From
Collaboration Deals in Biotechnology 2021-2026 - Product Thumbnail Image

Collaboration Deals in Biotechnology 2021-2026

  • Report
  • September 2026
  • 800 Pages
  • Global
From
Loading Indicator